Part 4/8:
As the trial progresses, the group experiences surreal disturbances—including insomnia. Dr. Burke reassures them, dismissing their concerns about the strange side effects and modifying the experimental parameters to keep them awake longer. This foreboding directive quickly spirals into chaos as participants' bodies and minds succumb to the experimental drug, which Burke learns is causing severe brain inflammation—information that she is forced to keep from the others.
A group that once seemed united slowly fractures as paranoia creeps in. The announcement of a financial incentive for staying until the trial's end splits their loyalties. Claire, alongside Amir, raises red flags about the integrity of their situation, while others blindly chase the promised bonus.